Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | (FY)Sep 30, 2019 | (FY)Sep 30, 2018 | |
---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||||
Cash from operating activities | -46.33%8.01M | -54.52%14.93M | -76.24%32.82M | -15.37%138.16M | -25.00%163.24M | -27.96%217.65M | 302.12M |
Net profit before non-cash adjustment | 82.44%-83.6M | -5,233.53%-476.03M | -92.70%9.27M | 0.18%127.11M | -38.42%126.88M | 22.23%206.04M | --168.57M |
Total adjustment of non-cash items | -80.66%94.99M | 2,475.88%491.2M | 35.60%19.07M | -74.04%14.06M | 530.54%54.18M | -74.61%8.59M | --33.85M |
-Depreciation and amortization | -96.47%2.82M | 69.27%79.87M | 94.20%47.19M | 11.58%24.3M | 24.60%21.78M | 30.47%17.48M | --13.4M |
-Reversal of impairment losses recognized in profit and loss | -98.07%7.48M | --387.41M | --0 | ---- | ---- | ---- | ---- |
-Disposal profit | --81.74M | --0 | ---- | --299K | ---- | ---- | --12.8M |
-Deferred income tax | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Other non-cash items | -87.66%2.95M | 185.06%23.92M | -166.93%-28.12M | -132.51%-10.53M | 464.71%32.4M | -216.09%-8.88M | --7.65M |
Changes in working capital | -1,343.59%-3.38M | -105.22%-234K | 248.82%4.48M | 83.09%-3.01M | -689.05%-17.81M | -96.97%3.02M | --99.7M |
-Change in receivables | -363.71%-12M | -69.02%4.55M | 439.49%14.69M | -50.94%2.72M | 176.76%5.55M | -110.14%-7.23M | --71.26M |
-Change in prepaid assets | 401.52%14.47M | 40.70%-4.8M | -71.50%-8.09M | -154.62%-4.72M | 276.76%8.64M | -232.75%-4.89M | --3.68M |
-Change in payables | -1,053.76%-4.06M | 0.47%426K | 180.30%424K | 97.51%-528K | -1,342.36%-21.23M | -92.82%1.71M | --23.81M |
-Change in accrued expense | -336.34%-1.79M | 83.83%-410K | -421.60%-2.54M | 95.48%-486K | -180.14%-10.76M | 1,313.68%13.43M | --950K |
Dividends paid (cash flow from operating activities) | |||||||
Dividends received (cash flow from operating activities) | |||||||
Interest paid (cash flow from operating activities) | |||||||
Interest received (cash flow from operating activities) | 1,300.00%14K | 0.00%1K | 0.00%1K | 0.00%1K | -87.50%1K | -93.60%8K | 125K |
Tax refund paid | -98.83%176K | 138.59%15.04M | -8.87%-38.98M | -80.60%-35.81M | -6,736.55%-19.83M | -9.43%-290K | -265K |
Other operating cash inflow (outflow) | 100.01%1K | -1,000,000.00%-10M | 200.00%1K | -1K | 0 | 0 | 0 |
Operating cash flow | -58.93%8.2M | 424.26%19.97M | -106.02%-6.16M | -28.63%102.35M | -34.02%143.42M | -28.02%217.37M | --301.98M |
Investing cash flow | |||||||
Net PPE purchase and sale | --0 | -104.13%-890K | ---436K | ---- | 88.58%-468K | 11.98%-4.1M | ---4.66M |
Net intangibles purchase and sale | 93.73%-10.79M | 29.69%-171.96M | -425.04%-244.58M | -100.39%-46.58M | 44.83%-23.25M | -167.66%-42.14M | ---15.74M |
Net investment product transactions | ---- | ---- | -8,895.20%-89.95M | ---1M | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | -68.45%726K | --2.3M |
Net changes in other investments | ---- | ---- | ---1K | ---- | ---1K | ---- | ---1K |
Investing cash flow | 93.76%-10.79M | 48.40%-172.85M | -603.97%-334.97M | -100.65%-47.58M | 47.89%-23.72M | -151.44%-45.51M | ---18.1M |
Financing cash flow | |||||||
Net common stock issuance | ---- | ---- | -44.09%15.66M | -92.91%28.01M | --394.96M | ---- | ---- |
Issuance fees | ---- | ---- | ---- | -221.69%-14.76M | ---4.59M | ---- | ---- |
Cash dividends paid | ---- | 99.99%-1K | ---19.28M | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | ---- | ---- | ---- | 0.00%-1K | ---1K | ---- | ---- |
Financing cash flow | --0 | 99.97%-1K | -127.33%-3.62M | -96.61%13.25M | --390.37M | ---- | ---- |
Net cash flow | |||||||
Beginning cash position | -15.51%832.86M | -25.91%985.73M | 5.39%1.33B | 67.79%1.26B | 29.60%752.39M | 95.69%580.53M | --296.65M |
Current changes in cash | 98.31%-2.59M | 55.66%-152.88M | -606.83%-344.75M | -86.66%68.02M | 196.80%510.07M | -39.46%171.86M | --283.88M |
Cash adjustments other than cash changes | ---- | 0.00%-2K | ---2K | ---- | --1K | ---- | ---- |
End cash Position | -0.31%830.27M | -15.51%832.86M | -25.91%985.73M | 5.39%1.33B | 67.79%1.26B | 29.60%752.39M | --580.53M |
Free cash flow | 98.31%-2.59M | 39.14%-152.88M | -550.38%-251.18M | -53.41%55.77M | -30.05%119.71M | -39.22%171.13M | --281.56M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |